Piccart M, Procter M, Fumagalli D, de Azambuja E, et al. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. J Clin Oncol 2021 Feb 4:JCO2001204. doi: 10.1200/JCO.20.01204.
PMID: 33539215